Aspirin may halt cancer spread
Jeremy Laurance is a writer on health issues. He is former health editor of The Independent and the i and has covered the specialism for more than 20 years. He thinks the harm medicine does is under-appreciated, the harm it prevents over-rated, and that cycling works better than most drugs. He was named Specialist Journalist of the Year in the 2011 British Press Awards.
Wednesday 21 March 2012
Aspirin, the most versatile drug in the pharmacy, which is already known to prevent cancer, may also be an effective treatment for halting the disease once it has started.
An analysis of five large trials of people who took a daily low dose aspirin showed that among those who developed cancer it reduced its spread to distant organs by 40 to 50 per cent.
The spread of cancer, or "metastasis", is what most commonly kills patients after the disease has been initially diagnosed and treated.
The study is one of three published in The Lancet and Lancet Oncology which shows that taking aspirin for as little as two or three years can have a beneficial effect against cancer.
Study leader Professor Peter Rothwell of the University of Oxford said: "It seems likely aspirin will be of benefit when started after cancer is diagnosed."
Life & Style blogs
- 1 Cameron's freebie to apartheid South Africa
- 2 Is this the scariest advert ever? Japanese tyre commercial comes with its own disclaimer and health warning
- 3 Sherlock series 3: Benedict Cumberbatch and Martin Freeman provide teasers for the biggest comeback in British television
- 4 A forgotten episode in Russian history leaves links with the Philippines
- 5 People will try to reduce Mandela to a lilting reggae tune about ‘love’. They will fail
- < Previous
- Next >
£50000 - £70000 per annum + Benefits : Harrington Starr: Senior Automation QA ...
£30000 - £40000 per annum + Bonus and Benefits: Harrington Starr: A global Con...
£31000 - £43000 per annum: Capita Education Resourcing Permanent Team: This se...
£27000 - £45000 per annum: Capita Education Resourcing Permanent Team: Lambeth...